Bohai Chemical: Stock trading experiencing abnormal fluctuations, planning to transfer partial equity of subsidiary.

Bohai Chemical announced that the closing price of the company's stock deviated by 20% for three consecutive trading days from March 24th to 26th, 2026, which is considered abnormal volatility. Upon self-examination, the company's production and operation are normal, and no undisclosed significant issues have been found. Currently, the company is planning to transfer part of the equity of its wholly-owned subsidiary Bohai Petrochemical to its controlling shareholder Bohai Group through a non-public agreement. The Board of Directors will convene soon to review and submit to the shareholders' meeting, which is expected not to constitute a major asset restructuring. In addition, the company expects a net loss of 632 to 665 million yuan for the year 2025, and reminds investors to pay attention to risks.